O‘TKIR MIOKARD INFARKTI DAVOSINI OPTIMALLASHTIRISH

It is reported that the introduction of thrombolytic (fibrinolytic) therapy into clinical practice has led to a decrease in the mortality rate of patients in the first month of therapy: the timing of thrombolysis from the onset of clinical manifestations of myocardial infarction. Alternative methods of coronary blood flow restoration, indications and contraindications, complications and side effects, methods for assessing the effectiveness of thrombolysis. Given the idea of fibrin-selective drugs. Various fibrinolytics of streptokinase, alteplaza, teneteplaza are described, analyzes the results of large randomized clinical trials on fibrinolytic therapy of myocardial infarction; discusses the possibilities of increasing the efficiency and safety of fibrinolytics by combing them with acetylsalicylic acid and heparins